The ESMO Congress serves as a globally influential platform in oncology, bringing together clinicians, researchers, patient advocates, journalists, and healthcare industry representatives from around the world. The STAMPEDE2 trial will be presented at the event, with each of its three comparisons detailed in a set of posters. Please find links to these posters below: ESMO STA ...